222 related articles for article (PubMed ID: 24343972)
1. CIITA: a master regulator of adaptive immunity shows its innate side in the bone.
Nakamura MC
J Bone Miner Res; 2014 Feb; 29(2):287-9. PubMed ID: 24343972
[No Abstract] [Full Text] [Related]
2. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
[TBL] [Abstract][Full Text] [Related]
3. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W
Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-specific MHCII expression is regulated by a remote
Buxadé M; Huerga Encabo H; Riera-Borrull M; Quintana-Gallardo L; López-Cotarelo P; Tellechea M; Martínez-Martínez S; Redondo JM; Martín-Caballero J; Flores JM; Bosch E; Rodríguez-Fernández JL; Aramburu J; López-Rodríguez C
J Exp Med; 2018 Nov; 215(11):2901-2918. PubMed ID: 30327417
[TBL] [Abstract][Full Text] [Related]
5. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
6. Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.
Forlani G; Shallak M; Ramia E; Tedeschi A; Accolla RS
Retrovirology; 2019 Nov; 16(1):34. PubMed ID: 31783769
[TBL] [Abstract][Full Text] [Related]
7. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A
J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.
Voong LN; Slater AR; Kratovac S; Cressman DE
J Biol Chem; 2008 Apr; 283(14):9031-9. PubMed ID: 18245089
[TBL] [Abstract][Full Text] [Related]
9. NLRC5: a key regulator of MHC class I-dependent immune responses.
Kobayashi KS; van den Elsen PJ
Nat Rev Immunol; 2012 Dec; 12(12):813-20. PubMed ID: 23175229
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun.
Kim D; Hoory T; Monie A; Ting JP; Hung CF; Wu TC
J Immunol; 2008 May; 180(10):7019-27. PubMed ID: 18453624
[TBL] [Abstract][Full Text] [Related]
11. ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.
Yoon HS; Scharer CD; Majumder P; Davis CW; Butler R; Zinzow-Kramer W; Skountzou I; Koutsonanos DG; Ahmed R; Boss JM
J Immunol; 2012 Sep; 189(5):2393-403. PubMed ID: 22851713
[TBL] [Abstract][Full Text] [Related]
12. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
14. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes.
Otten LA; Tacchini-Cottier F; Lohoff M; Annunziato F; Cosmi L; Scarpellino L; Louis J; Steimle V; Reith W; Acha-Orbea H
J Immunol; 2003 Feb; 170(3):1150-7. PubMed ID: 12538670
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
[TBL] [Abstract][Full Text] [Related]
17. CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments.
Zinzow-Kramer WM; Long AB; Youngblood BA; Rosenthal KM; Butler R; Mohammed AU; Skountzou I; Ahmed R; Evavold BD; Boss JM
Genes Immun; 2012 Jun; 13(4):299-310. PubMed ID: 22218223
[TBL] [Abstract][Full Text] [Related]
18. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
[TBL] [Abstract][Full Text] [Related]
19. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
[TBL] [Abstract][Full Text] [Related]
20. Function and regulation of class II transactivator in the immune system.
Chang CH; Gourley TS; Sisk TJ
Immunol Res; 2002; 25(2):131-42. PubMed ID: 11999167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]